Evidence map›Paper›PMID 34336132›Full record

ReviewInternational journal of physiology, pathophysiology and pharmacology2021

Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: a narrative review.

Ginenus Fekadu, Firomsa Bekele, Tadesse Tolossa, Getahun Fetensa, Ebisa Turi, Motuma Getachew, Eba Abdisa, Lemessa Assefa, Melkamu Afeta, Waktole Demisew and 3 more

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in International journal of physiology, pathophysiology and pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06044805 (Monitoring Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax Based on Clinical, Parasitologic and Hematologic Parameters in Shecha Health Center), which is not on this map. Cited by 90 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 2 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06044805 phase4completednot on this mapstarted 2022, after this paper: background citation

Monitoring Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax Based on Clinical, Parasitologic and Hematologic Parameters in Shecha Health Center: Open Label Clinical Trial

TypeinterventionalSponsorDinka DugassaRan2022 to 2023Enrolled100ConditionsEfficacy, Malaria, Chloroquine, Vivax MalariaArmsChloroquine, Primaquine
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Ginenus FekaduSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong Shatin, New Territory, Hong Kong.
Firomsa BekeleDepartment of Pharmacy, College of Health Sciences, Mettu University Mettu, Ethiopia.
Tadesse TolossaDepartment of Public Health, Institute of Health, Wollega University Nekemte, Ethiopia.
Getahun FetensaSchool of Nursing and Midwifery, Institute of Health Sciences, Wollega University Nekemte, Ethiopia.
Ebisa TuriDepartment of Public Health, Institute of Health, Wollega University Nekemte, Ethiopia.
Motuma GetachewDepartment of Public Health, Institute of Health, Wollega University Nekemte, Ethiopia.
Eba AbdisaSchool of Nursing and Midwifery, Institute of Health Sciences, Wollega University Nekemte, Ethiopia.
Lemessa AssefaDepartment of Public Health, Institute of Health, Wollega University Nekemte, Ethiopia.
Melkamu AfetaDepartment of Psychology, College of Education and Behavioral Studies, Kotobe Metropolitan University Addis Ababa, Ethiopia.
Waktole DemisewDepartment of Psychology, College of Behavioral Science, Wollega University Nekemte, Ethiopia.
Dinka DugassaSchool of Pharmacy, Institute of Health Sciences, Wollega University Nekemte, Ethiopia.
Dereje Chala DiribaSchool of Nursing and Midwifery, Institute of Health Sciences, Wollega University Nekemte, Ethiopia.
Busha Gamachu LabataSchool of Pharmacy, Institute of Health Sciences, Wollega University Nekemte, Ethiopia.
Wollega University · ETChinese University of Hong Kong · HKFitbit (United States) · USKotebe University of Education · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus is a respiratory disease that spreads globally. The severity and mortality risk of the disease is significant in the elderly, peoples having co-morbidities, and immunosuppressive patients. The outbreak of the pandemic created significant barriers to diagnosis, treatment and follow-up of chronic diseases. Delivering regular and routine comprehensive care for chronic patients was disrupted due to closures of healthcare facilities, lack of public transportation or reductions in services. The purpose of this narrative review was to update how patients with chronic care were affected during the pandemic, healthcare utilization services and available opportunities for better chronic disease management during the pandemic in resources limited settings. Moreover, this review may call to the attention of concerned bodies to make decisions and take measures in the spirit of improving the burden of chronic diseases by forwarding necessary recommendations for possible change and to scale up current intervention programs.

Indexed as

chronic diseasesCOVID-19follow-up careimpactlow resource settings

Identifiers

PMID34336132
PMCPMC8310882
OpenAlexW3192196303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.